how glp-1 drugs cause gastroparesis lawsuits Manufacturers Argue Should Require Contemporaneous Diagnostic Testing Drug-Induced Gastroparesis and Product Liability
Description
The aim of this trial was to investigate whether GLP-1 receptor agonists reduce fluid intake in patients with primary polydipsia
CPAA (2022) 14:1926
Trnblom H
At the same time, the company is dealing with thousands of lawsuits from people who say they were harmed by these drugs, and new cases are still being filed
Can I file a claim if I stopped taking the drug months ago
We have to consider GLP-1 drugs longer-term societal impact because they have the potential to be cost-effective years or decades down the line
